8:40am ET
Health and Healthcare
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
VRTX Coverage Page 12
8:10am ET
Investing
Top Analyst Upgrades and Downgrades: Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams, Xerox and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Tuesday, July 8, 2014. They include Abengoa Yield, CSC, Groupon, 3M, Vertex, Williams and Xerox.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Coach, J.C. Penney, Micron, Whole Foods, Vertex and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach, J.C. Penney, Micron Technology, Whole Foods and Vertex Pharmaceuticals.
1:15pm ET
Health and Healthcare
The Real Attraction to Vertex After Cystic Fibrosis Success
Vertex Pharmaceuticals has reported that two Phase 3 studies of its lumacaftor cystic fibrosis drug in combination with its Kalydeco ivacaftor showed positive results. Shares spikes on the news.
Paul Ausick 10:15am ET
Health and Healthcare
Upcoming Binary Events Could Lift These Health Care Stocks Much Higher
In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in the sector. Catalysts may move the stocks sharply either way, depending on…
8:20am ET
Health and Healthcare
After Idenix: The Next Four Biotech Buyout Candidates
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
8:35am ET
Investing
RBC Doctor Panel Picks in Drugs and Biotech
In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six physicians. They favor four top stocks now as best positioned for continued…
8:45am ET
Investing
These Top Stocks Are Cheap After Huge Market Sell-Off
ThinkstockIn just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity strategy team at Jefferies concede that the recent correction in share prices…
8:45am ET
Health and Healthcare
Catalysts That Could Push Top Biotech Stocks Even Higher
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In a new research report, Cowen highlights upcoming catalysts that could send some…
8:15am ET
Health and Healthcare
UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside
Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large cap biotech stocks are poised to beat earnings estimates across the board.…
8:15am ET
Health and Healthcare
UBS Has Nine Biotech Buyout and Merger Candidates
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this…
8:10am ET
Health and Healthcare
J.P. Morgan Top Biotechnology Stocks to Buy for 2014
Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is very…
9:00am ET
Investing
Ten Top Growth Stock Ideas for 2014 From Baird
Baird offers an eclectic and interesting list for investors. A top regional firm, it tends to dig a little deeper, looking for ideas with not only growth potential, but catalysts. The usual…
8:45am ET
Investing
Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More
These are the top analyst upgrades, initiations and positive analyst research calls seen from Wall Street on Monday, January 6.
8:30am ET
Health and Healthcare
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.